Cart
×
CureDuchenne Impact: CureDuchenne has invested more than $26M in research through grants and investments. Of that $26M, $22.2M in biotech investments has led to follow-on funding of more than $3B from other investors and companies to advance these programs further. CureDuchenne has a track record of successful investments, and its “stamp of approval” attracts future investments in these projects from VC firms, biotech companies, and pharmaceutical Companies.
IMPACT REPORT HERE